CD4 CAR T cells 비교 | 바이오정보모아

프로그램 상세에서 관심 등록 후 2개 이상 모으면 여기서 한 번에 비교할 수 있습니다.

프로그램 선택

Overview Technology MoA Clinical

표가 넓으면 좌우로 스크롤하세요. 핵심 비교 모드에서는 중요 항목만 표시됩니다.

항목	CGTStandard DatabasestalePhase 1 CD4 CAR T cells (CD4 CAR T cells) iCell Gene Therapeutics·FRα 39 trials

Overview Program	CD4 CAR T cells
Overview Company	iCell Gene Therapeutics
Overview Modality	CGT
Overview Target	FRα
Overview Indication	T Cell Lymphoma in Relapse; Refractory T-Cell Lymphoma
Overview Phase	PHASE_1
Overview Status	ACTIVE
Overview Content status	Standard Database
Overview Data Confidence	Editorial scope · structured catalog
Overview Development Signal	Development Signal · Watch
Overview Approval status	Investigational

Technology Vector	retroviral therapy (ART)

MoA Mechanism	targetable modulator of JAK-STAT signaling
MoA Biomarker	biomarker and therapeutic target in CAR T cell-associated neurotoxicity

Clinical Program phase	PHASE_1

프로그램 상세에서 관심 등록 후 2개 이상 모으면 여기서 한 번에 비교할 수 있습니다.

프로그램 선택

Overview Technology MoA Clinical

표가 넓으면 좌우로 스크롤하세요. 핵심 비교 모드에서는 중요 항목만 표시됩니다.

항목	CGTStandard DatabasestalePhase 1 CD4 CAR T cells (CD4 CAR T cells) iCell Gene Therapeutics·FRα 39 trials

Overview Program	CD4 CAR T cells
Overview Company	iCell Gene Therapeutics
Overview Modality	CGT
Overview Target	FRα
Overview Indication	T Cell Lymphoma in Relapse; Refractory T-Cell Lymphoma
Overview Phase	PHASE_1
Overview Status	ACTIVE
Overview Content status	Standard Database
Overview Data Confidence	Editorial scope · structured catalog
Overview Development Signal	Development Signal · Watch
Overview Approval status	Investigational

Technology Vector	retroviral therapy (ART)

MoA Mechanism	targetable modulator of JAK-STAT signaling
MoA Biomarker	biomarker and therapeutic target in CAR T cell-associated neurotoxicity

Clinical Program phase	PHASE_1